Armata Pharmaceuticals, Inc. (ARMP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.95M | 10.67M | 16.93M | 7.52M | 13.17M | 11.31M | 22.39M | 30.9M | 41.72M | 19.15M | 36.59M | 26.83M |
| Cash & Short-Term Investments | 4.75M | 8.69M | 14.76M | 4.33M | 11.69M | 9.29M | 17.14M | 26.41M | 37.86M | 13.52M | 23.96M | 12.46M |
| Cash Only | 4.75M | 8.69M | 14.76M | 4.33M | 11.69M | 9.29M | 17.14M | 26.41M | 37.86M | 13.52M | 23.96M | 12.46M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 47K | 472K | 759K | 2.17M | 238K | 744K | 2.22M | 1.24M | 1.71M | 3.36M | 8.5M | 0 |
| Days Sales Outstanding | 29.6 | - | - | 50.47 | 90 | 110.36 | 53.55 | - | 239.13 | 357.04 | 638.14 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.71M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.15M | 1.51M | 1.42M | 1.02M | 1.24M | 1.27M | 3.03M | 3.26M | 3.86M | 2.27M | 0 | 8.63M |
| Total Non-Current Assets | 63.85M | 66.21M | 72.59M | 73.27M | 74.08M | 75.13M | 75.85M | 77.41M | 78.64M | 79.21M | 76.18M | 74.38M |
| Property, Plant & Equipment | 45.17M | 46.1M | 52.48M | 53.16M | 53.97M | 54.93M | 55.87M | 57.15M | 56.94M | 57.28M | 54.14M | 52.46M |
| Fixed Asset Turnover | 0.02x | - | - | 0.04x | 0.01x | 0.02x | 0.05x | - | 0.02x | 0.03x | 0.02x | 0.02x |
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Intangible Assets | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 0 |
| Long-Term Investments | 4.12M | 5.39M | 0 | 0 | 5.39M | 5.48M | 0 | 5.48M | 5.48M | 0 | 0 | 0 |
| Other Non-Current Assets | 813K | 973K | 6.36M | 6.36M | 975K | 975K | 6.24M | 1.04M | 2.47M | 8.19M | 8.29M | 18.43M |
| Total Assets | 69.8M | 76.88M | 89.52M | 80.79M | 87.25M | 86.44M | 98.24M | 108.31M | 120.36M | 98.36M | 112.76M | 101.21M |
| Asset Turnover | 0.01x | - | - | 0.03x | 0.01x | 0.01x | 0.03x | - | 0.01x | 0.01x | 0.01x | 0.01x |
| Asset Growth % | -20% | -11.05% | -8.88% | -25.41% | -27.51% | -12.12% | -12.88% | 7.02% | 10.64% | 2.64% | 21.4% | 0.23% |
| Total Current Liabilities | 9.23M | 8.95M | 139.95M | 120.08M | 110.54M | 48.25M | 118.2M | 123.18M | 110.05M | 16.46M | 21.88M | 51.56M |
| Accounts Payable | 660K | 921K | 1.28M | 965K | 981K | 766K | 1.81M | 1.74M | 2.06M | 1.58M | 3.77M | 9.58M |
| Days Payables Outstanding | 155.68 | - | - | 241.92 | 208.53 | 312.44 | 522.9 | 548.89 | 522.75 | 841.03 | 2.78K | 3.32K |
| Short-Term Debt | 4.59M | 4.56M | 131.08M | 112.34M | 102.78M | 38.95M | 107.4M | 111.39M | 96.67M | 0 | 0 | 26.35M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.98M | 3.46M | 2.35M | 1.72M | 1.68M | 529K | 2.09M | 124K | 322K | 1.29M | 1.74M | 0 |
| Current Ratio | 0.64x | 1.19x | 0.12x | 0.06x | 0.12x | 0.23x | 0.19x | 0.25x | 0.38x | 1.16x | 1.67x | 0.52x |
| Quick Ratio | 0.64x | 1.19x | 0.12x | 0.06x | 0.12x | 0.23x | 0.19x | 0.25x | 0.39x | 1.16x | 1.67x | 0.52x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 372.16M | 286.53M | 45.15M | 30.21M | 30.49M | 86.21M | 31.01M | 31.23M | 66.82M | 113.97M | 103.26M | 30.51M |
| Long-Term Debt | 342.9M | 256.92M | 15.24M | 0 | 0 | 55.44M | 0 | 0 | 35.37M | 82.31M | 72.02M | 0 |
| Capital Lease Obligations | 26.18M | 26.53M | 26.84M | 27.13M | 27.42M | 27.69M | 27.93M | 28.16M | 28.38M | 28.58M | 28.16M | 27.43M |
| Deferred Tax Liabilities | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.08M |
| Total Liabilities | 381.39M | 295.48M | 185.1M | 150.29M | 141.03M | 134.46M | 149.21M | 154.41M | 176.87M | 130.43M | 125.15M | 82.07M |
| Total Debt | 373.67M | 288.02M | 177.68M | 143.96M | 134.66M | 126.52M | 140.33M | 146.14M | 167.91M | 120.37M | 113.63M | 68.31M |
| Net Debt | 368.92M | 279.33M | 162.93M | 139.63M | 122.97M | 117.22M | 123.19M | 119.73M | 130.05M | 106.85M | 89.67M | 55.85M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 3.57x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.58x | -24.71x | -5.14x | -3.28x | -0.81x | 1.79x | -0.88x | 4.31x | -12.75x | -12.69x | -25.50x | - |
| Total Equity | -311.59M | -218.6M | -95.59M | -69.5M | -53.78M | -48.02M | -50.97M | -46.1M | -56.51M | -32.06M | -12.39M | 19.14M |
| Equity Growth % | -479.34% | -355.23% | -87.53% | -50.76% | 4.83% | -49.76% | -311.54% | -340.82% | -351.75% | -188.87% | -127.18% | -64.08% |
| Book Value per Share | -8.53 | -6.01 | -2.64 | -1.92 | -1.49 | -0.81 | -1.41 | -0.79 | -1.56 | -0.89 | -0.34 | 0.53 |
| Total Shareholders' Equity | -311.59M | -218.6M | -95.59M | -69.5M | -53.78M | -48.02M | -50.97M | -46.1M | -56.51M | -32.06M | -12.39M | 19.14M |
| Common Stock | 366K | 364K | 362K | 362K | 362K | 362K | 362K | 362K | 361K | 361K | 361K | 361K |
| Retained Earnings | -616.88M | -501.53M | -377.24M | -350.56M | -334.27M | -327.74M | -330.33M | -324.85M | -333.84M | -308.82M | -288.97M | -257.81M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |